ERBB2 and breast carcinoma: In triple-negative breast cancer and HER2-positive breast cancer, high levels of TILs have been correlated with better overall survival (OS) and disease-free survival (DFS).[7] This correlation underscores the potential of TILs as a prognostic biomarker, particularly in aggressive breast cancer subtypes where traditional markers may be less predictive.